These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease? Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375 [TBL] [Abstract][Full Text] [Related]
4. Association of factor V Leiden with Behçet's disease. Mammo L; Al-Dalaan A; Bahabri SS; Saour JN J Rheumatol; 1997 Nov; 24(11):2196-8. PubMed ID: 9375883 [TBL] [Abstract][Full Text] [Related]
5. Abnormalities of T-cell subsets in Behçet's syndrome. Lim SD; Haw CR; Kim NI; Fusaro RM Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease. Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343 [TBL] [Abstract][Full Text] [Related]
7. Antiphosphatidylserine-prothrombin complex antibodies in 3 patients with Behçet disease involving superficial vein thrombophlebitis. Kawakami T; Yamazaki M; Mizoguchi M; Soma Y Arch Dermatol; 2009 Feb; 145(2):171-5. PubMed ID: 19221262 [TBL] [Abstract][Full Text] [Related]
8. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)]. Kagawa H; Okubo S Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the fibrinolytic system in Behçet's disease? Asbeck F; Meyer-Boernecke D; van de Loo J Haemostasis; 1977; 6(5):303-9. PubMed ID: 598751 [TBL] [Abstract][Full Text] [Related]
10. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506 [TBL] [Abstract][Full Text] [Related]
16. Decreased nitric oxide and increased platelet aggregation levels in patients with Behçet's disease. Yapişlar H; Aydogan S; Borlu M; Ascioglu O Thromb Res; 2007; 119(4):461-5. PubMed ID: 16806408 [No Abstract] [Full Text] [Related]
17. Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Probst K; Fijnheer R; Rothova A Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149 [TBL] [Abstract][Full Text] [Related]
18. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867 [TBL] [Abstract][Full Text] [Related]
19. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease. Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890 [TBL] [Abstract][Full Text] [Related]
20. [Activated protein C resistance in Behçet disease]. Guermazi S; M'Rad S; Lamloum M; Houman MH; Hamza M; Ben Dridi M; Miled M; Dellagi K Pathol Biol (Paris); 1998 Dec; 46(10):791-5. PubMed ID: 9922996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]